Member of the Association of American Physicians
David Feldman mostly deals with Internal medicine, Endocrinology, Receptor, Calcitriol receptor and Cell growth. The Endocrinology study combines topics in areas such as Cancer cell and Cell culture. His work carried out in the field of Receptor brings together such families of science as Hormone, Human skin, Estrogen receptor and Skeletal muscle.
His Calcitriol receptor research incorporates elements of FokI, Transactivation, Molecular biology, Genotype and Rickets. His study looks at the intersection of Cell growth and topics like In vitro with Melanoma, Keratin and Tumor cells. David Feldman usually deals with Vitamin D and neurology and limits it to topics linked to Vitamin and vitamin D deficiency.
David Feldman focuses on Internal medicine, Endocrinology, Receptor, Vitamin D and neurology and Calcitriol receptor. His Internal medicine study frequently draws connections to other fields, such as Cancer research. David Feldman studied Endocrinology and Cancer cell that intersect with Growth inhibition.
His research integrates issues of Kidney and Estrogen receptor in his study of Receptor. His Vitamin D and neurology research includes elements of Calcium metabolism, Cancer and Vitamin. In his research, Gene is intimately related to Molecular biology, which falls under the overarching field of Calcitriol receptor.
His main research concerns Vitamin D and neurology, Internal medicine, Endocrinology, Calcitriol receptor and Calcitriol. The study incorporates disciplines such as Cancer, Metastasis, Vitamin and Pharmacology in addition to Vitamin D and neurology. David Feldman works mostly in the field of Internal medicine, limiting it down to concerns involving Oncology and, occasionally, Breast cancer.
His Endocrinology study combines topics in areas such as Calcium metabolism and Calcium. His Calcitriol receptor research is included under the broader classification of Receptor. His Calcitriol research integrates issues from Cholecalciferol, Aromatase, Estrogen receptor and Prostate cancer.
David Feldman spends much of his time researching Internal medicine, Vitamin D and neurology, Endocrinology, Calcitriol and Calcitriol receptor. His research on Internal medicine often connects related topics like Oncology. David Feldman combines subjects such as Cancer, Vitamin and Clinical trial with his study of Vitamin D and neurology.
His Endocrinology research is multidisciplinary, relying on both Calcium metabolism, Receptor, Cancer research and Estrogen receptor. His Calcitriol course of study focuses on Aromatase and Estrogen and Adipose tissue. His Calcitriol receptor study incorporates themes from Molecular biology and Rickets.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The development of androgen-independent prostate cancer
Brian J. Feldman;David Feldman.
Nature Reviews Cancer (2001)
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving
Aruna V. Krishnan;Peter Stathis;Suzanne F. Permuth;Laszlo Tokes.
Endocrinology (1993)
The role of vitamin D in reducing cancer risk and progression
David Feldman;Aruna V. Krishnan;Srilatha Swami;Edward Giovannucci.
Nature Reviews Cancer (2014)
Beyond universals in cognitive development
David Henry Feldman.
(1980)
Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle.
E W McCleskey;A P Fox;D H Feldman;L J Cruz.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Nature's Gambit : Child Prodigies and the Development of Human Potential
David Henry Feldman;Lynn T. Goldsmith.
(1986)
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.
Kay Colston;M. Joseph Colston;David Feldman.
Endocrinology (1981)
Inhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate
R L Wagner;P F White;P B Kan;M H Rosenthal.
The New England Journal of Medicine (1984)
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
Xiao Yan Zhao;Peter J. Malloy;Aruna V. Krishnan;Srilatha Swami.
Nature Medicine (2000)
Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 on Primary Cultures of Human Prostatic Cells
Donna M. Peehl;Roman J. Skowronski;Gordon K. Leung;Stephen T. Wong.
Cancer Research (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
Stanford University
KU Leuven
University of Wisconsin–Madison
Stanford University
Claremont Graduate University
New York University
Stanford University
California Institute for Medical Research
Cornell University
Royal Institute of Technology
University of Illinois at Urbana-Champaign
University of Salerno
The Ohio State University
Osaka University
University of Arizona
Korea University
Temple University
Harvard University
University of Montpellier
University of Maryland, College Park
University of Pecs
AstraZeneca (United Kingdom)
International Agency For Research On Cancer
University of British Columbia
University of Washington